The survival analysis was performed with all cancer types in the TCGA project (Figure 1A), suggesting BNIP3 mRNA expression as a worse prognostic factor also for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), cholangiocarcinoma (CHOL), and sarcoma (SARC). This evidence concerns the gene BNIP3 and cholangiocarcinoma.